| 2026-03-30 |
详情>>
内部人交易：
Floyd Heather M等共交易11笔
|
| 2026-03-09 |
详情>>
业绩披露：
2026年年报每股收益9.68美元,归母净利润2.81亿美元,同比去年增长20.47%
|
| 2026-03-05 |
详情>>
股本变动：
变动后总股本2997.01万股
|
| 2026-03-04 |
财报披露：
美东时间 2026-03-04 盘前发布财报
|
| 2025-11-20 |
详情>>
业绩披露：
2026年三季报(累计)每股收益9.15美元,归母净利润2.65亿美元,同比去年增长31.96%
|
| 2025-08-21 |
详情>>
业绩披露：
2026年中报每股收益5.48美元,归母净利润1.59亿美元,同比去年增长21.06%
|
| 2025-05-22 |
详情>>
业绩披露：
2026年一季报每股收益2.11美元,归母净利润6104.80万美元,同比去年增长-2.41%
|
| 2025-04-11 |
股东大会：
将于2025-05-22召开股东大会
会议内容 ▼▲
- 1.Elect the three directors named in the Proxy Statement;
2.Approve, by non-binding advisory vote, executive compensation;
3.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal 2026;
4.Transact such other business as may properly be brought before the Annual Meeting, and any adjournments or postponements of the Annual Meeting.
|
| 2025-02-28 |
详情>>
业绩披露：
2023年年报每股收益4.81美元,归母净利润1.42亿美元,同比去年增长192.78%
|
| 2025-02-28 |
详情>>
业绩披露：
2025年年报每股收益8.02美元,归母净利润2.33亿美元,同比去年增长6.62%
|
| 2024-11-21 |
详情>>
业绩披露：
2024年三季报(累计)每股收益6.66美元,归母净利润1.96亿美元,同比去年增长66.52%
|
| 2024-11-21 |
详情>>
业绩披露：
2025年三季报(累计)每股收益6.89美元,归母净利润2.01亿美元,同比去年增长2.68%
|
| 2024-08-22 |
详情>>
业绩披露：
2025年中报每股收益4.50美元,归母净利润1.31亿美元,同比去年增长17.16%
|
| 2024-05-23 |
详情>>
业绩披露：
2025年一季报每股收益2.15美元,归母净利润6255.40万美元,同比去年增长21.41%
|
| 2024-04-12 |
股东大会：
将于2024-05-23召开股东大会
会议内容 ▼▲
- 1.Elect the two directors named in the Proxy Statement;
2.Approve, by non-binding advisory vote, executive compensation;
3.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal 2025;
4.Transact such other business as may properly be brought before the Annual Meeting, and any adjournments or postponements of the Annual Meeting.
|
| 2024-03-01 |
详情>>
业绩披露：
2024年年报每股收益7.46美元,归母净利润2.19亿美元,同比去年增长53.94%
|
| 2023-04-14 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.Elect the two directors named in the Proxy Statement;
2.Approve, by non-binding advisory vote, executive compensation;
3.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal 2024;
4.Approve an amendment and restatement of the 2017 Non-Employee Director’s Equity Plan to, among other things, increase the number of authorized shares by 95,000 shares;
5.Approve, by non-binding advisory vote, the frequency of future advisory votes on executive compensation;
6.Transact such other business as may properly be brought before the Annual Meeting, and any adjournments or postponements of the Annual Meeting.
|
| 2022-04-15 |
股东大会：
将于2022-05-26召开股东大会
会议内容 ▼▲
- 1.Elect the four directors named in the Proxy Statement;
2.Approve, by non-binding advisory vote, executive compensation;
3.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal 2023;
4.Approve an amendment and restatement to the Company's 2012 Long-Term Incentive Plan to, among other things, increase the number of authorized shares by 650,000 shares;
5.Transact such other business as may properly be brought before the Annual Meeting, and any adjournments or postponements of the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-15 |
股东大会：
将于2021-05-25召开股东大会
会议内容 ▼▲
- 1.Election of Director Nominees
2.Advisory Vote to Approve Executive Compensation
3.Appointment of the Independent Auditor
|
| 2020-04-09 |
股东大会：
将于2020-05-19召开股东大会
会议内容 ▼▲
- 1.Elect the three directors named in the Proxy Statement;
2.Approve, by non-binding advisory vote, executive compensation;
3.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal 2021;
4.Transact such other business as may properly be brought before the Annual Meeting, and any adjournments or postponements of the Annual Meeting.
|
| 2019-04-11 |
股东大会：
将于2019-05-21召开股东大会
会议内容 ▼▲
- 1.Elect the four directors named in the Proxy Statement;
2.Approve, by non-binding advisory vote, executive compensation;
3.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal 2020;
4.Approve an amendment to the Company’s 2012 Long-Term Incentive Plan to increase the number of authorized shares by 550,000 shares;
5.Transact such other business as may properly be brought before the Annual Meeting, and any adjournments or postponements of the Annual Meeting.
|
| 2018-04-12 |
股东大会：
将于2018-05-22召开股东大会
会议内容 ▼▲
- 1.Elect the four directors named in the Proxy Statement;
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal 2019;
3.Approve, by non-binding advisory vote, executive compensation;
4.Transact such other business as may properly be brought before the Annual Meeting, and any adjournments or postponements of the Annual Meeting.
|
| 2017-10-12 |
股东大会：
将于2017-11-21召开股东大会
会议内容 ▼▲
- 1.Elect the two directors named in the Proxy Statement;
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for the six-month transition period of July 30, 2017 to January 27, 2018;
3.Approve, by non-binding advisory vote, executive compensation;
4.Recommend, by non-binding advisory vote, the frequency of future advisory votes on executive compensation;
5.Approve an amendment and restatement of the Company’s 2012 Long-Term Incentive Plan, including an increase in the number of authorized shares and the reapproval of performance goals under the plan;
6.Approve the Company’s 2017 Non-Employee Directors Equity Plan;
7.Transact such other business as may properly be brought before the Annual Meeting, and any adjournments or postponements of the Annual Meeting.
|
| 2016-10-13 |
股东大会：
将于2016-11-22召开股东大会
会议内容 ▼▲
- 1. To Elect the two directors named in the Proxy Statement;
2. To Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal 2017;
3. To Approve a non-binding advisory vote on executive compensation;
4. To Transact such other business as may properly be brought before the Annual Meeting, and any adjournments or postponements of the Annual Meeting.
|
| 2015-10-15 |
股东大会：
将于2015-11-24召开股东大会
会议内容 ▼▲
- 1.Elect four directors named in the Proxy Statement;
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal 2016;
3.Approve a non-binding advisory vote on executive compensation;
4.Transact such other business as may properly be brought before the Annual Meeting, and any adjournments or postponements of the Annual Meeting.
|